GFAP and diabetes mellitus: Glial cells may also endure significant modifications in case of diabetes, as demonstrated by the dysfunctional interconversion of glutamate and glutamine [64], the altered regulation of potassium channels [65], and the activation of glutamate-aspartate transporter and intermediate filament proteins, such as the glial fibrillary acidic protein (GFAP).